Biomarkers in Obstructive Sleep Apnea Surgery

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Eric Kezirian, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00507078
First received: July 23, 2007
Last updated: May 18, 2012
Last verified: May 2012

July 23, 2007
May 18, 2012
June 2005
Not Provided
Leptin, homocysteine, and C-reactive protein levels. [ Time Frame: Before and after surgery ]
Same as current
Complete list of historical versions of study NCT00507078 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Biomarkers in Obstructive Sleep Apnea Surgery
Biomarkers in Obstructive Sleep Apnea Surgery

Recent years have witnessed major advances in the understanding of the hormonal, metabolic, and biochemical changes that occur in obstructive sleep apnea (OSA). This project evaluates the biomarkers that measure the most significant health impacts of this disorder and creates a specimen bank that will facilitate evaluations of additional biomarkers in the future.

This is a case-control study to examine the relationship between obstructive sleep apnea (OSA) and elevated levels of leptin, homocysteine, and C-reactive protein (CRP) in moderate or severe OSA and control patients. This is followed by a prospective cohort study to examine the relationship between surgical treatment of moderate or severe OSA and serum levels of these biomarkers.

The short-term goals of this study consider the abnormalities in biomarker levels associated with OSA and specific aspects of the disorder as well as whether the changes seen after surgical treatment of OSA mirror those demonstrated after efficacious non-surgical treatment. The long term goals are in two areas: 1) the development of measures to determine which patients require treatment for sleep-disordered breathing and to monitor the effectiveness of therapy, and 2) a deeper understanding of the connection between OSA and its adverse health consequences.

Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Obstructive Sleep Apnea
Procedure: Surgical treatment for OSA
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
June 2007
Not Provided

Inclusion Criteria:

  • OSA group is adults with moderate or severe OSA (apnea >= 15 based on preoperative sleep study) undergoing surgical treatment. Assessment is done prior to surgery.
  • Control group is overweight (body mass >25) adults without OSA (apnea-hypopnea index <5 based on sleep study) or other sleep disorders. Assessment is prior to treatment.
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00507078
522315-38198
No
Eric Kezirian, University of California, San Francisco
University of California, San Francisco
Not Provided
Principal Investigator: Eric Kezirian, MD, MPH University of California, San Francisco
University of California, San Francisco
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP